Ornella Elizabeth Bentkowski, PA-C

Ornella Bentkowski practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Ornella Bentkowski's NPI, 1780191460, was assigned on January 4, 2018. Ornella Bentkowski holds Texas license PA11579.

Ornella Bentkowski's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Ornella Bentkowski's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Ornella Bentkowski is also affiliated with HCA Houston Healthcare Clear Lake. The medical group on file is Physicians Referral Service. Dmand AI also links Ornella Bentkowski to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ornella Bentkowski practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Ornella Bentkowski's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Ornella Bentkowski is licensed in Texas.

CMS data shows 32 Medicare services from Ornella Bentkowski across 2 procedure codes in 2024, for 36 Medicare patients. Medicare paid $2,178 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 36 Medicare patients who saw Ornella Bentkowski in 2024. The largest group is 65 to 74, with 12 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ornella Bentkowski's median patient age at 62, with 100% women.

In 2024, Ornella Bentkowski wrote 19 Medicare Part D claims. 95% of them were for generic drugs.

Ornella Bentkowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Ornella Bentkowski from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Kerecis Limited paid the most, $26.